433 related articles for article (PubMed ID: 34948035)
1. The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.
Egaña-Huguet J; Soria-Gómez E; Grandes P
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948035
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and Endocannabinoid Signaling in Epilepsy.
Katona I
Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids and glial cells: possible mechanism to understand schizophrenia.
de Almeida V; Martins-de-Souza D
Eur Arch Psychiatry Clin Neurosci; 2018 Oct; 268(7):727-737. PubMed ID: 29392440
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of the endocannabinoid system in glial cells.
Massi P; Valenti M; Bolognini D; Parolaro D
Curr Pharm Des; 2008; 14(23):2289-98. PubMed ID: 18781979
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.
Luongo L; Maione S; Di Marzo V
Eur J Neurosci; 2014 Feb; 39(3):401-8. PubMed ID: 24494680
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
7. Bench to bedside: Multiple facets of cannabinoid control in epilepsy.
Xue B; Zhang X; Wang Y
Neurochem Int; 2020 Dec; 141():104898. PubMed ID: 33159980
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system in normal and pathological brain ageing.
Bilkei-Gorzo A
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3326-41. PubMed ID: 23108550
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms Mediating Involvement of Glial Cells in Brain Plastic Remodeling in Epilepsy.
Khaspekov LG; Frumkina LE
Biochemistry (Mosc); 2017 Mar; 82(3):380-391. PubMed ID: 28320280
[TBL] [Abstract][Full Text] [Related]
10. The role of endocannabinoids in pain modulation.
Zogopoulos P; Vasileiou I; Patsouris E; Theocharis SE
Fundam Clin Pharmacol; 2013 Feb; 27(1):64-80. PubMed ID: 23278562
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of human epileptic neocortex predicts vascular and glial changes in epileptic regions.
Keren-Aviram G; Dachet F; Bagla S; Balan K; Loeb JA; Dratz EA
PLoS One; 2018; 13(4):e0195639. PubMed ID: 29634780
[TBL] [Abstract][Full Text] [Related]
13. Role of the endocannabinoid system in Alzheimer's disease: new perspectives.
Pazos MR; Núñez E; Benito C; Tolón RM; Romero J
Life Sci; 2004 Sep; 75(16):1907-15. PubMed ID: 15306158
[TBL] [Abstract][Full Text] [Related]
14. Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE).
Luongo L; Starowicz K; Maione S; Di Marzo V
Pharmacol Res; 2017 May; 119():272-277. PubMed ID: 28237514
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R; Ambwani SR; Singh S
Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
[TBL] [Abstract][Full Text] [Related]
16. Glial cell changes in epilepsy: overview of the clinical problem and therapeutic opportunities.
Hubbard JA; Hsu MS; Fiacco TA; Binder DK
Neurochem Int; 2013 Dec; 63(7):638-51. PubMed ID: 23376026
[TBL] [Abstract][Full Text] [Related]
17. Microglia-Neuron Communication in Epilepsy.
Eyo UB; Murugan M; Wu LJ
Glia; 2017 Jan; 65(1):5-18. PubMed ID: 27189853
[TBL] [Abstract][Full Text] [Related]
18. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures.
Lutz B
Biochem Pharmacol; 2004 Nov; 68(9):1691-8. PubMed ID: 15450934
[TBL] [Abstract][Full Text] [Related]
19. Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.
Sharma S; Puttachary S; Thippeswamy T
J Neurosci Res; 2019 Nov; 97(11):1363-1377. PubMed ID: 29230865
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders.
Sagredo O; Palazuelos J; Gutierrez-Rodriguez A; Satta V; Galve-Roperh I; Martínez-Orgado J
Biochem Pharmacol; 2018 Nov; 157():85-96. PubMed ID: 30118663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
